Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Companies

Set Alert for Companies

Livongo Names Zane Burke New CEO; Jennifer Schneider Becomes President

Zane Burke is the new CEO of Livongo Health, the applied health signals company announced Dec. 18. Burke previously spent five years as president of health IT company Cerner Corp. Livongo also announced that Chief Medical Officer Jennifer Schneider has been promoted to president, overseeing product, data science, software engineering, marketing, and clinical operations.

Appointments Artificial Intelligence Digital Health
Advertisement

Latest From Companies

Abbott Advances Transcath Mitral Valve Efforts With Cephea Acquisition

Abbott has exercised an option to buy Cephea Valve Technologies, developer of a minimally-invasive replacement heart valve, for an undisclosed sum.

Cardiovascular M & A

Medtech Money Flow: M&A & VC Deals, Jan. 7-13, 2019

This edition of Medtech Money Flow rounds up the M&A and venture financing deals, as recorded in our M&A and VC Deal Trackers, from Jan. 7-13, 2019.

M & A Financing

GE Healthcare Forges Five-Year Precision Medicine Partnership With Vanderbilt

GE Healthcare is making a bid to become the leader in precision medicine by collaborating with Vanderbilt University Medical Center to develop AI-powered diagnostic tools for cancer care.

Artificial Intelligence Personalized Medicine

Nexstim Targets Canadian Market With New Distributor Agreement

Neuromodulation firm Nexstim will launch its SmartFocus TMS system for treating major depressive disorder (MDD) in Canada after signing an exclusive agreement with distributor Canada Health Solutions CHS.

Canada Deals

Medtech Money Flow: M&A & VC Deals, Dec. 31, 2018-Jan. 6, 2019

This edition of Medtech Money Flow rounds up the M&A and venture financing deals, as recorded in our M&A and VC Deal Trackers, from Dec. 31, 2018, through Jan. 6, 2019.

Financing M & A

Device Week, Jan. 4, 2019 – Reviewing A Record Year For M&A In Medtech

In this edition of Device Week, Medtech Insight's Catherine Longworth reviews the year in mergers and acquisitions, including big moves by Medtronic, Stryker and Boston Scientific. Looking forward to 2019, companies will be looking for acquisitions to help them take advantage of the emergence of Asia as the second-biggest device market, respond to Brexit, and potentially cope with new device regulations around the world.

Device Week M & A

Johnson & Johnson Joins Forces With Veracyte For Lung Cancer Diagnostics

Johnson & Johnson has entered a strategic collaboration with genomics diagnostics company Veracyte to develop and commercialize tests for detecting lung cancer.

Deals Cancer

AMS Names New CFO

Wound care specialist Advanced Medical Solutions (AMS) has appointed a new CFO following the retirement of Mary Tavener. 
Appointments Commercial

Boston Scientific Makes A Move In Mitral Valve, Sealing $325M Deal With Millipede

Boston Scientific has acquired the remaining shares of privately held mitral-valve repair device company Millipede for $325m.

Cardiovascular M & A
See All
UsernamePublicRestriction

Register